Author  
Place of duty  
Title   ÀÓ½ÅÁß ¹ß°ßµÈ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ 1¿¹ ( A Case of Acute Myelogenous Leukemia during Pregnancy )
Publicationinfo   1997 Jan; 029(03): 516-521.
Key_word   Acute myelogenous leukemia, Pregnancy
Full-Text  
Abstract   The incidence of acute leukemia in pregnancy is rare. The treatment of acute leukemia during pregnancy is complicated and therapeutic options must be made with each individual patient. Complete remission can now be achieved in 60 to 70% of previously untreated adults with acute myelogenous leukemia(AML). Antileukemic chemotherapy can be administered safely during the second and third trimesters. Cytarabine(ara-C) and anthracycline has not been associated with birth defect. When a pregnant woman presents with acute leukemia, chemotherapy should be recommended as vigorously as in the nonpregnant woman. We reported a case of AML during pregnancy. The patient recieved induction chemotherapy with ara-C and idarubicin. The baby was delivered at 33 weeks of gestation and had transient neutropenia. The mother received consolidation chemotherapy after achievement of complete remission.
Àú ÀÚ   ÀÌÀç±Õ(Jae Kyun Lee),¾ç¼ºÇö(Sung Hyun Yang),±èÈïÅÂ(Heung Tae Kim)